Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adherence to Mediterranean diet, high-sensitive C-reactive protein, and severity of coronary artery disease: Contemporary data from the INTERCATH cohort.
Waldeyer C, Brunner FJ, Braetz J, Ruebsamen N, Zyriax BC, Blaum C, Kroeger F, Kohsiack R, Schrage B, Sinning C, Becher PM, Karakas M, Zeller T, Westermann D, Sydow K, Blankenberg S, Seiffert M, Schnabel RB. Waldeyer C, et al. Among authors: blaum c. Atherosclerosis. 2018 Aug;275:256-261. doi: 10.1016/j.atherosclerosis.2018.06.877. Epub 2018 Jun 22. Atherosclerosis. 2018. PMID: 29980052
Association of high-sensitivity troponin T and I with the severity of stable coronary artery disease in patients with chronic kidney disease.
Brunner FJ, Kröger F, Blaum C, Goßling A, Lorenz T, van Erckelens E, Brätz J, Westermann D, Blankenberg S, Zeller T, Waldeyer C, Seiffert M. Brunner FJ, et al. Among authors: blaum c. Atherosclerosis. 2020 Nov;313:81-87. doi: 10.1016/j.atherosclerosis.2020.09.024. Epub 2020 Sep 28. Atherosclerosis. 2020. PMID: 33032237
The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithm of the 2017 ESC consensus statement: a simulation study in a contemporary CAD cohort.
Blaum C, Seiffert M, Goßling A, Kröger F, Bay B, Lorenz T, Braetz J, Graef A, Zeller T, Schnabel R, Clemmensen P, Westermann D, Blankenberg S, Brunner FJ, Waldeyer C. Blaum C, et al. Eur J Prev Cardiol. 2021 Mar 23;28(1):47-56. doi: 10.1093/eurjpc/zwaa088. Eur J Prev Cardiol. 2021. PMID: 33580772
Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population.
Blaum C, Brunner FJ, Kröger F, Braetz J, Lorenz T, Goßling A, Ojeda F, Koester L, Karakas M, Zeller T, Westermann D, Schnabel R, Blankenberg S, Seiffert M, Waldeyer C. Blaum C, et al. Eur J Prev Cardiol. 2021 Apr 10;28(2):152–158. doi: 10.1177/2047487319885458. Epub 2019 Nov 10. Eur J Prev Cardiol. 2021. PMID: 33838040 Free article.
Association of High-Sensitivity Troponin T and I Blood Concentrations With All-Cause Mortality and Cardiovascular Outcome in Stable Patients-Results From the INTERCATH Cohort.
Bay B, Goßling A, Blaum CM, Kroeger F, Koppe L, Lorenz T, Koester L, Clemmensen P, Westermann D, Kirchhof P, Blankenberg S, Zeller T, Seiffert M, Waldeyer C, Brunner FJ. Bay B, et al. Among authors: blaum cm. J Am Heart Assoc. 2022 Sep 6;11(17):e024516. doi: 10.1161/JAHA.121.024516. Epub 2022 Jul 19. J Am Heart Assoc. 2022. PMID: 35862141 Free PMC article.
Publisher Correction: Inflammatory burden, lifestyle and atherosclerotic cardiovascular disease: insights from a population based cohort study.
Bay B, Blaum C, Kellner C, der Kellen RB, Ojeda F, Waibel J, Arnold N, Behrendt CA, Rimmele DL, Thomalla G, Twerenbold R, Blankenberg S, Zyriax B, Brunner FJ, Waldeyer C. Bay B, et al. Among authors: blaum c. Sci Rep. 2024 Jan 8;14(1):790. doi: 10.1038/s41598-024-51444-6. Sci Rep. 2024. PMID: 38191581 Free PMC article. No abstract available.
125 results